Brief: Ryvu Therapeutics Signs Deal With Medical Research Agency For Up to 62.3 Mln Zloty Subsidy
July 31 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* SIGNS DEAL WITH MEDICAL RESEARCH AGENCY
* DEAL ON ABOUT 62.3 MILLION ZLOTY SUBSIDY FOR RIVER-81
PROJECT
* AIM OF PROJECT IS TO DEVELOP A NEW TREATMENT STRATEGY FOR
ACUTE
MYELOID LEUKEMIA (AML) BY CONDUCTING RIVER-81 STUDY
Source text for Eikon: ID:nEMxwCJPa
Further company coverage: RVU.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys